Tetsuo Shimizu

2.8k total citations
95 papers, 968 citations indexed

About

Tetsuo Shimizu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tetsuo Shimizu has authored 95 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Tetsuo Shimizu's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Neuroendocrine Tumor Research Advances (10 papers). Tetsuo Shimizu is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Neuroendocrine Tumor Research Advances (10 papers). Tetsuo Shimizu collaborates with scholars based in Japan, Germany and Australia. Tetsuo Shimizu's co-authors include S Murphy, Yasuhiro Gon, Shuichiro Maruoka, Kenji Mizumura, Shu Hashimoto, Noriaki Takahashi, Mari Hikichi, Yoshiko Nakagawa, Yuko Iida and Yoko Nakanishi and has published in prestigious journals such as Blood, Cancer and European Respiratory Journal.

In The Last Decade

Tetsuo Shimizu

87 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuo Shimizu Japan 18 319 293 159 154 129 95 968
Monique P. Gelderman United States 19 682 2.1× 140 0.5× 57 0.4× 190 1.2× 207 1.6× 40 1.6k
Tulika Chandra India 18 250 0.8× 85 0.3× 54 0.3× 180 1.2× 54 0.4× 60 1.1k
H.A. Leaver United Kingdom 20 335 1.1× 223 0.8× 119 0.7× 65 0.4× 38 0.3× 61 1.1k
Roger C. Carroll United States 20 190 0.6× 233 0.8× 23 0.1× 80 0.5× 99 0.8× 48 1.4k
Christopher P. Steffes United States 23 348 1.1× 279 1.0× 114 0.7× 149 1.0× 38 0.3× 54 1.4k
Sveinn Guðmundsson Iceland 18 250 0.8× 70 0.2× 23 0.1× 40 0.3× 199 1.5× 34 847
Carmela Fiorito Italy 20 324 1.0× 66 0.2× 94 0.6× 47 0.3× 58 0.4× 38 908
Demet Nalbant United States 18 309 1.0× 129 0.4× 26 0.2× 50 0.3× 89 0.7× 38 897
John C. Kermode United States 16 432 1.4× 68 0.2× 67 0.4× 61 0.4× 33 0.3× 40 1.2k
Douglas S. Palmer Canada 18 282 0.9× 94 0.3× 32 0.2× 38 0.2× 238 1.8× 50 1.2k

Countries citing papers authored by Tetsuo Shimizu

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Shimizu more than expected).

Fields of papers citing papers by Tetsuo Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Shimizu. The network helps show where Tetsuo Shimizu may publish in the future.

Co-authorship network of co-authors of Tetsuo Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Shimizu. A scholar is included among the top collaborators of Tetsuo Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Shimizu. Tetsuo Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Hiromichi, Shun Ito, Katsuhiro Miura, et al.. (2025). Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma. Annals of Hematology. 104(2). 1047–1057. 1 indexed citations
2.
Murakami, Haruyasu, Nobuaki Mamesaya, Shota Omori, et al.. (2024). Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer. Thoracic Cancer. 15(21). 1665–1672. 1 indexed citations
3.
4.
Gon, Yasuhiro, Kenji Mizumura, Yutaka Kozu, et al.. (2023). Anti-UBE2T antibody: A novel biomarker of progressive-fibrosing interstitial lung disease. Respiratory Investigation. 61(5). 579–587.
5.
Nakanishi, Yoko, Hiroko Kobayashi, Xiaoyan Tang, et al.. (2023). Different effects of crizotinib treatment in two non‐small cell lung cancer patients with SDC4::ROS1 fusion variants. Thoracic Cancer. 15(1). 89–93. 1 indexed citations
6.
Shimizu, Tetsuo, et al.. (2019). A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer. Journal of International Medical Research. 47(7). 3079–3087. 6 indexed citations
7.
Mizumura, Kenji, Shuichiro Maruoka, Tetsuo Shimizu, & Yasuhiro Gon. (2018). Autophagy, selective autophagy, and necroptosis in COPD. International Journal of COPD. Volume 13. 3165–3172. 48 indexed citations
8.
Iida, Yuko, Yoichi Nakanishi, Nobunori Takahashi, et al.. (2017). P1.03-009 A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment. Journal of Thoracic Oncology. 12(11). S1954–S1954. 2 indexed citations
9.
Osaka, Eiji, et al.. (2016). Lung squamous cell carcinoma with brachial soft tissue metastasis responsive to gefitinib: Report of a rare case. Thoracic Cancer. 7(6). 676–680. 3 indexed citations
10.
Takahashi, Noriaki, Yoshihiro Sato, Tetsuo Shimizu, & Shu Hashimoto. (2014). End of life care for lung cancer patients. 24(2). 175–178. 1 indexed citations
11.
Shimizu, Tetsuo, et al.. (2006). Effect of bicarbonated Ringer's solution on PaCO(2 )and tissue PO(2 )in hemorrhagic shock rats. Critical Care. 10(Suppl 1). P178–P178. 2 indexed citations
12.
Takahashi, Hitoshi, Keizo Yoshida, Hisashi Higuchi, et al.. (2003). Addition of a Dopamine Agonist, Cabergoline, to a Serotonin-Noradrenalin Reuptake Inhibitor, Milnacipran as a Therapeutic Option in the Treatment of Refractory Depression: Two Case Reports. Clinical Neuropharmacology. 26(5). 230–232. 16 indexed citations
13.
Fujita, Yuka, Satoru Fujiuchi, Yutaka Nishigaki, et al.. (2003). The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma. Cancer. 98(5). 1008–1013. 46 indexed citations
14.
Takahashi, Noriaki, et al.. (2002). The Diagnostic Value of Bronchial Arteriography for Hemoptysis. 24(2). 75–79. 1 indexed citations
15.
Suzuki, Ko, et al.. (2001). Comparison of platelet quality in washed platelet concentrates prepared with different synthetics storage solutions.. Journal of the Japan Society of Blood Transfusion. 47(5). 777–782. 2 indexed citations
16.
Yamasaki, Masao, Tetsuo Shimizu, M. Miyake, et al.. (1999). Frequency distribution of axon diameters in the left aortic nerve of the rat raised in space--Neurolab Program.. PubMed. 13(3). 188–9. 2 indexed citations
17.
18.
Shimizu, Tetsuo, et al.. (1990). A case of primary fibrous histiocytoma of the lung.. The Journal of the Japanese Society of Clinical Cytology. 29(6). 877–882. 1 indexed citations
19.
Shimizu, Tetsuo, et al.. (1982). . KOBUNSHI RONBUNSHU. 39(5). 339–344. 3 indexed citations
20.
Shimizu, Tetsuo, et al.. (1965). Basicity and Cationic Copolymerizability of Lactones. The Journal of the Society of Chemical Industry Japan. 68(12). 2473–2476. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique P. Gelderman Breakdown of academic impact, for papers by Tulika Chandra Breakdown of academic impact, for papers by H.A. Leaver Breakdown of academic impact, for papers by Roger C. Carroll Breakdown of academic impact, for papers by Christopher P. Steffes Breakdown of academic impact, for papers by Sveinn Guðmundsson Breakdown of academic impact, for papers by Carmela Fiorito Breakdown of academic impact, for papers by Demet Nalbant Breakdown of academic impact, for papers by John C. Kermode Breakdown of academic impact, for papers by Douglas S. Palmer
Rankless by CCL
2026